Table 2.
Clinical characteristics of validation study participants by weight category.
| Variable | Normal weight control (mean ± SD) | Obese patients (mean ± SD) | p value |
|---|---|---|---|
| Demographic data | |||
| Sex (male) (n (%)) | 15 (100%) | 16 (100%) | |
| Age (years) | 27.22 ± 1.77 | 27.45 ± 1.79 | 0.696 |
|
| |||
| Anthropometric measurements | |||
| BMI (kg/m2) | 21.19 ± 1.35 | 32.01 ± 1.91 | 0.0001 |
| WC (cm) | 76.57 ± 7.89 | 105.96 ± 6.17 | 0.0001 |
| HC (cm) | 93.14 ± 5.02 | 110.37 ± 5.26 | 0.0001 |
| WHR | 0.82 ± 0.06 | 0.96 ± 0.04 | 0.0001 |
| Fat percentage (%) | 25.07 ± 4.89 | 32.64 ± 4.09 | 0.0001 |
|
| |||
| Biochemical characteristics | |||
| Glu (mmol/L) | 5.07 ± 3.15 | 5.35 ± 3.65 | 0.016 |
| HBA1C (%) | 5.13 ± 0.20 | 5.43 ± 0.43 | 0.0001 |
| TC (mmol/L) | 4.67 ± 0.83 | 5.83 ± 1.29 | 0.002 |
| TG (mmol/L) | 0.92 ± 0.38 | 2.71 ± 1.97 | 0.001 |
| HDL (mmol/L) | 1.54 ± 0.29 | 1.13 ± 0.21 | 0.0001 |
| LDL (mmol/L) | 2.69 ± 0.64 | 3.67 ± 1.00 | 0.001 |
| Insulin (IU/L) | 6.42 ± 2.64 | 19.37 ± 8.48 | 0.0001 |
The data are presented as mean ± SD, and the p value was calculated using a two-tailed test; significant p values are indicated in bold. BMI, body mass index; WC, waist circumference; HP, hip circumference; WHR, the rate of WC to HP; Glu, glucose; HbAlc, glycosylated hemoglobin; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoproteins; LDL, low-density lipoproteins.